Video ThumbnailVideo Thumbnail

Pharma companies may post near double-digital fall in Q4 PAT

Pharmaceutical companies are likely to report dismal number in Q4 of FY18 due to sustained pricing pressure, customer consolidation, rising competition and rupee appreciation.

See more

Recommended Videos